There were 688 press releases posted in the last 24 hours and 158,434 in the last 365 days.

Minimally Invasive Surgical (MIS) Devices:Medical Devices Pipeline Assessment 2016

Wise.Guy.

Minimally Invasive Surgical (MIS) Devices Medical Devices Pipeline Assessment, 2016

PUNE, INDIA, November 16, 2016 /EINPresswire.com/ -- The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Minimally Invasive Surgical (MIS) Devices pipeline products.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/729487-minimally-invasive-surgical-mis-devices-medical-devices-pipeline-assessment-2016

Scope
- Extensive coverage of the Minimally Invasive Surgical (MIS) Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Minimally Invasive Surgical (MIS) Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Minimally Invasive Surgical (MIS) Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction 9
2.1 Minimally Invasive Surgical (MIS) Devices Overview 9
3 Products under Development 10
3.1 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Stage of Development 10
3.2 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Territory 11
3.3 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Regulatory Path 12
3.4 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Estimated Approval Date 13
3.5 Minimally Invasive Surgical (MIS) Devices - Ongoing Clinical Trials 14
4 Minimally Invasive Surgical (MIS) Devices - Pipeline Products under Development by Companies 15
4.1 Minimally Invasive Surgical (MIS) Devices Companies - Pipeline Products by Stage of Development 15
4.2 Minimally Invasive Surgical (MIS) Devices - Pipeline Products by Stage of Development 17
5 Minimally Invasive Surgical (MIS) Devices Companies and Product Overview 18
5.1 Actuated Medical, Inc. Company Overview 18
5.1.1 Actuated Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 BriteSeed Company Overview 20
5.2.1 BriteSeed Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Delft University of Technology Company Overview 21
5.3.1 Delft University of Technology Pipeline Products & Ongoing Clinical Trials Overview 21
5.4 DistalMotion Company Overview 24
5.4.1 DistalMotion Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 ES Vascular Ltd. Company Overview 26
5.5.1 ES Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Ethicon Endo-Surgery, Inc. Company Overview 27
5.6.1 Ethicon Endo-Surgery, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 Eximis Company Overview 28
5.7.1 Eximis Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 FlexDex Company Overview 29
5.8.1 FlexDex Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Fortimedix B.V. Company Overview 31
5.9.1 Fortimedix B.V. Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Hadassah Medical Center Company Overview 32
5.10.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Human Extensions LTD Company Overview 33
5.11.1 Human Extensions LTD Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Imperial College London Company Overview 34
5.12.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 John Hopkins University Company Overview 35
5.13.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Osaka University Company Overview 36
5.14.1 Osaka University Pipeline Products & Ongoing Clinical Trials Overview 36
5.15 Rambam Health Care Campus Company Overview 37
5.15.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 37
5.16 Signum Surgical Ltd Company Overview 38
5.16.1 Signum Surgical Ltd Pipeline Products & Ongoing Clinical Trials Overview 38
5.17 Technische Universiteit Eindhoven Company Overview 39
5.17.1 Technische Universiteit Eindhoven Pipeline Products & Ongoing Clinical Trials Overview 39
5.18 UltraSurge Technologies Ltd. Company Overview 40
5.18.1 UltraSurge Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.19 University of California, San Francisco Company Overview 41
5.19.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 41
5.20 University of Wisconsin Madison Company Overview 45
5.20.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Varada Innovations Inc. Company Overview 47
5.21.1 Varada Innovations Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
5.22 VenX Medical LLC Company Overview 48
5.22.1 VenX Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 XACT Robotics Ltd. Company Overview 51
5.23.1 XACT Robotics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
6 Minimally Invasive Surgical (MIS) Devices- Recent Developments 52
6.1 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 52
6.2 Oct 26, 2016: Life Spine Achieves 32% Sales Growth and Announces Industry’s Largest Post-Packing Capabilities for Lateral Fusion 52
6.3 Oct 18, 2016: Intuitive Surgical Announces Third Quarter Earnings 53
6.4 Oct 17, 2016: Fortimedix Surgical Announces the U.S. Launch of symphonX Surgical Platform, the World’s Lowest Profile Single-Port Surgery Solution, During American College of Surgeons Clinical Congress 2016 54
6.5 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 54

Access Report @ https://www.wiseguyreports.com/reports/729487-minimally-invasive-surgical-mis-devices-medical-devices-pipeline-assessment-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here